{"id":149235,"date":"2026-11-11T18:38:00","date_gmt":"2026-11-11T09:38:00","guid":{"rendered":"https:\/\/japanir.jp\/en\/ir\/6090-20261111-02_wp_financial_summary\/"},"modified":"2026-11-11T18:38:00","modified_gmt":"2026-11-11T09:38:00","slug":"6090-20261111-02_wp_financial_summary","status":"publish","type":"ir_release","link":"https:\/\/japanir.jp\/en\/company\/company-6090\/ir\/6090-20261111-02_wp_financial_summary\/","title":{"rendered":"FY ending June 2027 First Quarter Financial Summary [Japanese GAAP] (Consolidated)"},"content":{"rendered":"<p>Net sales were 253,163 thousand yen, up 31.6% year-over-year. Operating loss was 4,709 thousand yen, ordinary loss was 687 thousand yen, and quarterly net loss attributable to owners of the parent was 3,233 thousand yen. Full-year forecasts remain unchanged. Treasury stock did not remain unchanged; net assets decreased due to recording the quarterly net loss.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"6090","jir_company_name":"Human Metabolome Technologies, Inc.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-11-11","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/11\/6090-20261111-02.pdf","jir_short_summary":"Net sales were 253,163 thousand yen, up 31.6% year-over-year. Operating loss was 4,709 thousand yen, ordinary loss was 687 thousand yen, and quarterly net loss attributable to owners of the parent was 3,233 thousand yen. Full-year forecasts remain unchanged. Treasury stock did not remain unchanged; net assets decreased due to recording the quarterly net loss.","jir_summary":"### Performance Overview\nFor the quarter, net sales were 253,163 thousand yen (up 31.6% year-over-year), demonstrating steady growth. Operating loss was 4,709 thousand yen, ordinary loss was 687 thousand yen, and quarterly net loss attributable to owners of the parent was 3,233 thousand yen. Gross profit was 162,890 thousand yen, supported by a decrease in cost of sales and an increase in backlog. The full-year earnings forecast remains unchanged from the previous announcement.\n\n### Financial Position, Cash Position and Dividends\nTotal assets were 1,974,259 thousand yen and net assets were 1,700,630 thousand yen. Treasury stock was 375,923 thousand yen (at fiscal year-end), and dividends remain undisclosed as in the prior year. Cash and deposits decreased significantly; current assets were 1,424,133 thousand yen and current liabilities were 260,989 thousand yen. Attention is required regarding the decline in net assets and the status of treasury stock holdings.","jir_financial_highlights":"Net Sales: 253,163 thousand yen (Up 31.6% Year-over-Year)\nOperating Loss: -4,709 thousand yen (Improved from operating loss of -91,141 thousand yen in the same period last year)\nOrdinary Loss: -687 thousand yen (Improved from ordinary loss of -90,522 thousand yen in the same period last year)\nQuarterly Net Loss Attributable to Owners of Parent: -3,233 thousand yen (Improved from loss of -97,176 thousand yen in the same period last year)\nQuarterly Net Loss per Share: -0.59 yen (Substantially improved from -17.10 yen in the same period last year)","jir_category":"","jir_hashtags":"#HumanMetabolomeTechnologies, #FinancialResults, #QuarterlyResults","jir_key_figures":"Net Sales: 253,163 thousand yen\nOperating Loss: -4,709 thousand yen\nOrdinary Loss: -687 thousand yen\nQuarterly Net Loss Attributable to Owners of Parent: -3,233 thousand yen\nQuarterly Net Loss per Share: -0.59 yen","jir_meta_title":"Human Metabolome Technologies, Inc. FY ending June 2027 Q1 Financial Summary | Sales Growth and Profitability Improvement","jir_meta_description":"Key points from Human Metabolome Technologies, Inc.'s FY ending June 2027 Q1 financial summary: net sales 253,163 thousand yen (up 31.6% YoY). Operating loss 4,709 thousand yen, ordinary loss 687 thousand yen, net loss 3,233 thousand yen. Full-year forecast unchanged.","jir_og_title":"Human Metabolome Technologies, Inc. FY ending June 2027 Q1 Financial Summary","jir_og_description":"Net sales increased significantly year-over-year, though a quarterly net loss was recorded. No change to the full-year forecast. Note the decrease in net assets and the status of treasury stock.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":60381,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-149235","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>FY ending June 2027 First Quarter Financial Summary [Japanese GAAP] (Consolidated) - Japan IR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/japanir.jp\/en\/company\/company-6090\/ir\/6090-20261111-02_wp_financial_summary\/\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-6090\/ir\/6090-20261111-02_wp_financial_summary\/\",\"url\":\"https:\/\/japanir.jp\/en\/company\/company-6090\/ir\/6090-20261111-02_wp_financial_summary\/\",\"name\":\"FY ending June 2027 First Quarter Financial Summary [Japanese GAAP] (Consolidated) - Japan IR\",\"isPartOf\":{\"@id\":\"https:\/\/japanir.jp\/en\/#website\"},\"datePublished\":\"2026-11-11T09:38:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-6090\/ir\/6090-20261111-02_wp_financial_summary\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/japanir.jp\/en\/company\/company-6090\/ir\/6090-20261111-02_wp_financial_summary\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-6090\/ir\/6090-20261111-02_wp_financial_summary\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/japanir.jp\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FY ending June 2027 First Quarter Financial Summary [Japanese GAAP] (Consolidated)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/japanir.jp\/en\/#website\",\"url\":\"https:\/\/japanir.jp\/en\/\",\"name\":\"Japan IR\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/japanir.jp\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FY ending June 2027 First Quarter Financial Summary [Japanese GAAP] (Consolidated) - Japan IR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/japanir.jp\/en\/company\/company-6090\/ir\/6090-20261111-02_wp_financial_summary\/","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/japanir.jp\/en\/company\/company-6090\/ir\/6090-20261111-02_wp_financial_summary\/","url":"https:\/\/japanir.jp\/en\/company\/company-6090\/ir\/6090-20261111-02_wp_financial_summary\/","name":"FY ending June 2027 First Quarter Financial Summary [Japanese GAAP] (Consolidated) - Japan IR","isPartOf":{"@id":"https:\/\/japanir.jp\/en\/#website"},"datePublished":"2026-11-11T09:38:00+00:00","breadcrumb":{"@id":"https:\/\/japanir.jp\/en\/company\/company-6090\/ir\/6090-20261111-02_wp_financial_summary\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/japanir.jp\/en\/company\/company-6090\/ir\/6090-20261111-02_wp_financial_summary\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/japanir.jp\/en\/company\/company-6090\/ir\/6090-20261111-02_wp_financial_summary\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/japanir.jp\/en\/"},{"@type":"ListItem","position":2,"name":"FY ending June 2027 First Quarter Financial Summary [Japanese GAAP] (Consolidated)"}]},{"@type":"WebSite","@id":"https:\/\/japanir.jp\/en\/#website","url":"https:\/\/japanir.jp\/en\/","name":"Japan IR","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/japanir.jp\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"related_company_data":{"id":"60381","title":"HUMAN METABOLOME TECHNOLOGIES I","ticker":"6090"},"_links":{"self":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/ir-release\/149235","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/ir-release"}],"about":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/types\/ir_release"}],"replies":[{"embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/comments?post=149235"}],"version-history":[{"count":0,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/ir-release\/149235\/revisions"}],"wp:attachment":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/media?parent=149235"}],"wp:term":[{"taxonomy":"sector","embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/sector?post=149235"},{"taxonomy":"importance","embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/importance?post=149235"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}